Anti-CD8 Polyclonal Antibody

データシート

• 商品コード：bs-0648R
• メーカー：BIS
• 包装：100μl
• 価格： ¥64,000
• 在庫：無(発注済)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Zhang, Wen, et al. The role of CXCR3 in the induction of primary biliary cirrhosis. Clinical and Developmental Immunology 2011 (2011).
  Zhang, W. et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 2
• 文献情報：
  He, Qiushan, et al. Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer. Cancer Immunology, Immunotherapy 60.5 (2011): 715-730.
  He, Q. et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 3
• 文献情報：
  Lee MF et al. The development of a murine model for Forcipomyia taiwana (biting midge) allergy. PLoS ONE 2014;9(3):e91871
  Lee MF et al
  2014/01/01
  
• 備考：
  
• 参照：
  

• No.： 4
• 文献情報：
  Jeong KY et al. Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma. J. Radiat. Res. 2014 Sep;
  Jeong KY et al
  2014/01/01
  
• 備考：
  
• 参照：
  

• No.： 5
• 文献情報：
  Ashraf MI et al. Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation. Am. J. Transplant. 2015 Nov;
  Ashraf MI et al
  2015/01/01
  
• 備考：
  Sample_Species: Mouse, Sample_Tissues: Kidney, Application_Area: IHC-P
• 参照：
  

• No.： 6
• 文献情報：
  Kovtun A et al. The crucial role of neutrophil granulocytes in bone fracture healing. Eur Cell Mater 2016 Jul;32:152-62
  Kovtun A et al
  2016/01/01
  
• 備考：
  applications: IHC-P, cross_reactive_species: Mouse, sample_tissue: Osteotomised femora
• 参照：
  

• No.： 7
• 文献情報：
  Li Y et al. Immunogenic FEAT protein circulates in the bloodstream of cancer patients. J Transl Med 2016 Sep;14(1):275
  Li Y et al
  2016/01/01
  
• 備考：
  applications: IHC-P, cross_reactive_species: Mouse, sample_tissue: tumor
• 参照：
  

• No.： 8
• 文献情報：
  Ju H et al. An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model. BMC Immunol. 2016 Sep;17(1):31
  Ju H et al
  2016/01/01
  
• 備考：
  applications: IHC-P, cross_reactive_species: Mouse, sample_tissue: lymph nodes
• 参照：
  

• No.： 9
• 文献情報：
  Wang RM et al. Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials. Biomaterials 2017 Jun;129:98-110
  Wang RM et al
  2017/01/01
  
• 備考：
  applications: IHC, cross_reactive_species: Mouse
• 参照：
  

• No.： 10
• 文献情報：
  Qiao X et al. Increased expression of Tim-3 and its ligand Galectin-9 in rat allografts during acute rejection episodes. Biochem. Biophys. Res. Commun. 2014 Mar;445(3):542-8
  Qiao X et al
  2014/01/01
  
• 備考：
  applications: IHC-F, cross_reactive_species: Rat
• 参照：
  

• No.： 11
• 文献情報：
  Chuang MH et al. The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response. BMC Complement Altern Med 2017 Apr;17(1):210
  Chuang MH et al
  2017/01/01
  
• 備考：
  applications: IHC-P, cross_reactive_species: Mouse
• 参照：
  

• No.： 12
• 文献情報：
  Haffner-Luntzer M et al. The inflammatory phase of fracture healing is influenced by oestrogen status in mice. Eur. J. Med. Res. 2017 Jul;22(1):23
  Haffner-Luntzer M et al
  2017/01/01
  
• 備考：
  applications: FCM, cross_reactive_species: Mouse
• 参照：
  

• No.： 13
• 文献情報：
  Willett ES et al. Standardized Rat Model Testing Effects of Inflammation and Grafting on Extraction Healing. J. Periodontol. 2017 Aug;88(8):799-807
  Willett ES et al
  2017/01/01
  
• 備考：
  applications: IHC, cross_reactive_species: Rat
• 参照：
  

• No.： 14
• 文献情報：
  Kroner J et al. Mast Cells Are Critical Regulators of Bone Fracture-Induced Inflammation and Osteoclast Formation and Activity. J. Bone Miner. Res. 2017 Aug;
  Kroner J et al
  2017/01/01
  
• 備考：
  applications: IHC-P, cross_reactive_species: Mouse
• 参照：
  

• No.： 15
• 文献情報：
  Tanaka R et al. The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model. Am J Cancer Res 2017;7(8):1693-1703
  Tanaka R et al
  2017/01/01
  
• 備考：
  applications: IHC-P, cross_reactive_species: Mouse
• 参照：
  

• No.： 16
• 文献情報：
  Wan WJ et al. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy. Int J Pharm 2019 Jul;566:731-744
  Wan WJ et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 17
• 文献情報：
  Demontoux L et al. Hypotonic stress enhances colon cancer cell death induced by platinum derivatives and immunologically improves antitumor efficacy of intraperitoneal chemotherapy. Int J Cancer 2019 12;145(11):3101-3111
  Demontoux L et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Sun J et al. Clinical effects of lentinan combined with budesonide inhalation in treating acute exacerbation of chronic obstructive pulmonary disease under mechanical ventilation. Exp Ther Med 2019 Mar;17(3):1503-1508
  Sun J et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 19
• 文献情報：
  Zhang Y et al. Knockout of beta-2 microglobulin reduces stem cell-induced immune rejection and enhances ischaemic hindlimb repair via exosome/miR-24/Bim pathway. J Cell Mol Med 2020 01;24(1):695-710
  Zhang Y et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 20
• 文献情報：
  Yuan SJ et al. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer. J Nanobiotechnology 2019 Oct;17(1):110
  Yuan SJ et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 21
• 文献情報：
  Li TF et al. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma. Biomaterials 2018 10;181:35-52
  Li TF et al
  2018/01/01
  
• 備考：
  
• 参照：